Pharmacy

The FINANCIAL -- Amgen on April 24 announced financial results for the first quarter of 2018. Key results include:

The FINANCIAL -- Elias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018,...

The FINANCIAL -- Pfizer Inc. on April 23 announced that TRUMENBA (Meningococcal Group B Vaccine) received Breakthrough Therapy designation from...

The FINANCIAL -- Pfizer Inc. on April 23 announced that the European Commission has approved MYLOTARG (gemtuzumab ozogamicin) in combination...

The FINANCIAL -- Eli Lilly and Company on April 24 announced financial results for the first quarter of 2018.

The FINANCIAL -- Abbott on April 18 announced financial results for the first quarter ended March 31, 2018.

The FINANCIAL -- Johnson & Johnson on April 17 announced sales of $20.0 billion for the first quarter of 2018,...

The FINANCIAL -- GSK and Orchard Therapeutics on April 12 announced a strategic agreement, under which GSK will transfer its...

The FINANCIAL -- Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing...

The FINANCIAL -- Novartis on April 4 announced that JAMA Cardiology has published results from a post-hoc analysis demonstrating that...

The FINANCIAL -- Eli Lilly and Company on April 4 announced top-line results from its Phase 3 REACH-2 study of...

The FINANCIAL -- Amgen on April 2 announced that the European Commission (EC) has approved an expanded indication for XGEVA...

The FINANCIAL -- The European Medicines Agency (EMA) has accepted for review an application for Dupixent (dupilumab) as an add-on...

The FINANCIAL -- Amgen on March 29 announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...

The FINANCIAL -- Novartis announced on March 27 that it has entered into an agreement with GlaxoSmithKline plc (GSK) to...